Michael Packer is a seasoned professional in the field of biophysics and liver therapeutics, currently serving as Sr. Director at Beam Therapeutics since July 2017. Initially the first employee at Beam, Michael has progressed through various roles, contributing to target identification and leading efforts in rare disease therapeutics within the liver team. Prior academic experience includes a PhD in Biophysics from Harvard University, where contributions were made to the evolution of proteases in David R. Liu's group, along with roles as a Graduate Teaching Fellow and an academic tutor. Earlier research experience encompasses positions at Cornell University and the Itai Cohen Lab, focusing on molecular medicine and experimental physics.
This person is not in any teams
This person is not in any offices